ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for MLAB

Stock NameMesa Laboratories Inc
TickerMLAB(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS59064R1095
LEI549300ZCG738WLX8ZW79

Show aggregate MLAB holdings

News associated with MLAB

Implied VIOO Analyst Target Price: $124
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-19 08:09:35
Choreo LLC Decreases Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)
Choreo LLC lowered its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 3.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,887 shares of the medical instruments supplier’s stock after selling 165 shares during the quarter. Choreo LLC owned 0.09% […] - 2025-07-28 05:46:54
Bank of New York Mellon Corp Boosts Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)
Bank of New York Mellon Corp lifted its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 2.7% during the first quarter, Holdings Channel reports. The institutional investor owned 54,767 shares of the medical instruments supplier’s stock after acquiring an additional 1,463 shares during the quarter. Bank of New York Mellon Corp’s holdings in […] - 2025-07-24 04:20:52
Mesa Laboratories (NASDAQ:MLAB) Downgraded by Wall Street Zen to “Buy”
Wall Street Zen lowered shares of Mesa Laboratories (NASDAQ:MLAB – Free Report) from a strong-buy rating to a buy rating in a research note issued to investors on Friday morning. Separately, Wells Fargo & Company decreased their price target on Mesa Laboratories from $120.00 to $100.00 and set an “underweight” rating on the stock in […] - 2025-06-02 04:20:57
Ameriprise Financial Inc. Acquires 99,819 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)
Ameriprise Financial Inc. boosted its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 191.8% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 151,862 shares of the medical instruments supplier’s stock after purchasing an additional 99,819 shares during the period. Ameriprise Financial Inc.’s holdings in Mesa Laboratories were worth $20,026,000 as of […] - 2025-05-16 05:01:15
Implied IJT Analyst Target Price: $153
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-15 07:40:17
Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Sold by Dimensional Fund Advisors LP
Dimensional Fund Advisors LP trimmed its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 7.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 113,850 shares of the medical instruments supplier’s stock after selling 9,723 shares during the […] - 2025-05-09 05:02:47
Short Interest in Mesa Laboratories, Inc. (NASDAQ:MLAB) Rises By 20.1%
Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report) was the recipient of a large increase in short interest in April. As of April 15th, there was short interest totalling 224,300 shares, an increase of 20.1% from the March 31st total of 186,700 shares. Based on an average trading volume of 44,100 shares, the short-interest ratio […] - 2025-05-05 05:30:49
Mesa Laboratories, Inc. (NASDAQ:MLAB) Stake Decreased by CANADA LIFE ASSURANCE Co
CANADA LIFE ASSURANCE Co reduced its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 7.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,927 shares of the medical instruments supplier’s stock after selling 577 shares during the quarter. […] - 2025-04-30 05:44:12
Analysts Expect SPTM To Hit $83
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-02 08:02:55
Choreo LLC Grows Stock Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)
Choreo LLC lifted its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 38.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,052 shares of the medical instruments supplier’s stock after purchasing an additional 1,392 shares during […] - 2025-02-11 06:46:52
Mesa Laboratories (NASDAQ:MLAB) Shares Up 12.3% After Better-Than-Expected Earnings
Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report)’s stock price was up 12.3% during mid-day trading on Tuesday after the company announced better than expected quarterly earnings. The stock traded as high as $143.94 and last traded at $150.43. Approximately 4,303 shares changed hands during trading, a decline of 85% from the average daily volume […] - 2025-02-06 04:08:53
Mesa Laboratories (NASDAQ:MLAB) Hits New 12-Month High After Earnings Beat
Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report)’s stock price reached a new 52-week high on Wednesday following a stronger than expected earnings report. The company traded as high as $152.75 and last traded at $137.27, with a volume of 68479 shares traded. The stock had previously closed at $133.93. The medical instruments supplier reported […] - 2025-02-05 04:40:49

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc MLAB holdings

DateNumber of MLAB Shares HeldBase Market Value of MLAB SharesLocal Market Value of MLAB SharesChange in MLAB Shares HeldChange in MLAB Base ValueCurrent Price per MLAB Share HeldPrevious Price per MLAB Share Held
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of MLAB by Blackrock for IE00B3VWM098

Show aggregate share trades of MLAB

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-08-21SELL-266.91069.510 69.250USD -139 114.02 Profit of 90 on sale
2025-08-06SELL-462.01062.910 62.820USD -251 116.14 Profit of 213 on sale
2025-08-04SELL-476.50076.850 76.815USD -307 116.68 Profit of 159 on sale
2025-07-31BUY676.48080.400 80.008USD 480 117.13
2025-07-28SELL-277.26078.310 78.205USD -156 117.80 Profit of 79 on sale
2025-07-25SELL-275.62075.630 75.629USD -151 118.04 Profit of 85 on sale
2025-06-30SELL-494.22098.910 98.441USD -394 121.95 Profit of 94 on sale
2025-06-25SELL-297.990100.590 100.330USD -201 122.42 Profit of 44 on sale
2025-06-20SELL-495.82096.270 96.225USD -385 122.91 Profit of 107 on sale
2025-05-23BUY2109.850111.540 111.371USD 223 126.18
2025-05-19SELL-2118.550122.200 121.835USD -244 126.55 Profit of 9 on sale
2025-05-15SELL-6121.350123.270 123.078USD -738 126.62 Profit of 21 on sale
2025-05-12SELL-2128.000131.200 130.880USD -262 126.66 Loss of -8 on sale
2025-05-09SELL-2123.840125.700 125.514USD -251 126.69 Profit of 2 on sale
2025-04-30SELL-2115.250116.790 116.636USD -233 127.16 Profit of 21 on sale
2025-04-24SELL-4116.320117.480 117.364USD -469 127.53 Profit of 41 on sale
2025-04-17SELL-2112.010113.610 113.450USD -227 128.26 Profit of 30 on sale
2025-04-15SELL-6115.520117.850 117.617USD -706 128.53 Profit of 65 on sale
2025-04-14SELL-6114.090116.510 116.268USD -698 128.67 Profit of 74 on sale
2025-04-09SELL-8116.920118.770 118.585USD -949 129.12 Profit of 84 on sale
2025-04-07SELL-14109.040113.770 113.297USD -1,586 129.57 Profit of 228 on sale
2025-04-04SELL-20108.000110.370 110.133USD -2,203 129.79 Profit of 393 on sale
2025-03-31BUY2118.660119.900 119.776USD 240 130.14
2025-03-19SELL-4124.240125.530 125.401USD -502 130.70 Profit of 21 on sale
2025-03-14SELL-12126.180127.740 127.584USD -1,531 130.83 Profit of 39 on sale
2025-03-13SELL-4122.330123.520 123.401USD -494 130.93 Profit of 30 on sale
2025-03-12SELL-68123.420128.250 127.767USD -8,688 131.03 Profit of 222 on sale
2025-03-07SELL-4137.540142.190 141.725USD -567 131.09 Loss of -43 on sale
2025-03-06SELL-6138.210139.140 139.047USD -834 131.00 Loss of -48 on sale
2025-03-03SELL-2135.440140.100 139.634USD -279 130.78 Loss of -18 on sale
2025-02-28SELL-12139.380140.160 140.082USD -1,681 130.66 Loss of -113 on sale
2025-02-26SELL-2144.500147.590 147.281USD -295 130.40 Loss of -34 on sale
2025-02-25SELL-6144.360146.680 146.448USD -879 130.20 Loss of -97 on sale
2025-02-18BUY10144.960146.660 146.490USD 1,465 128.68
2025-02-13BUY2145.630145.630 145.630USD 291 127.84
2025-02-12BUY2142.630149.660 148.957USD 298 127.60
2025-02-11BUY6150.500154.260 153.884USD 923 127.21
2025-02-06BUY18141.730143.270 143.116USD 2,576 126.09
2025-01-27BUY2139.490140.500 140.399USD 281 124.07
2025-01-22SELL-4144.850147.060 146.839USD -587 122.84 Loss of -96 on sale
2025-01-17SELL-2139.610144.910 144.380USD -289 121.47 Loss of -46 on sale
2025-01-16BUY2137.160137.820 137.754USD 276 121.09
2025-01-14BUY6131.050132.990 132.796USD 797 120.47
2025-01-13BUY4131.100133.000 132.810USD 531 120.19
2025-01-08BUY12142.030142.040 142.039USD 1,704 118.54
2024-12-30BUY10132.040133.120 133.012USD 1,330 117.73
2024-12-06BUY8124.000124.270 124.243USD 994 116.70
2024-12-05BUY2123.000125.500 125.250USD 251 116.48
2024-12-04BUY10126.330126.540 126.519USD 1,265 116.13
2024-11-29BUY10117.140119.550 119.309USD 1,193 115.60
2024-11-27BUY8118.350119.730 119.592USD 957 115.36
2024-11-26BUY2116.450117.720 117.593USD 235 115.31
2024-11-21BUY10100.860102.920 102.714USD 1,027 116.49
2024-11-20BUY698.590101.340 101.065USD 606 117.49
2024-11-18BUY24103.050103.930 103.842USD 2,492 119.50
2024-11-12BUY16112.400119.680 118.952USD 1,903 119.97
2024-11-08BUY10118.840120.340 120.190USD 1,202 120.05
2024-11-07BUY30117.890133.550 131.984USD 3,960 120.22
2024-11-06BUY4134.160140.540 139.902USD 560 119.06
2024-10-31BUY2114.040115.320 115.192USD 230 119.67
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MLAB

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1950,326068,05274.0%
2025-09-1836,525048,23075.7%
2025-09-1734,714049,66169.9%
2025-09-1634,101065,10052.4%
2025-09-1576,0480143,71952.9%
2025-09-1260,1010101,87159.0%
2025-09-1144,811074,31460.3%
2025-09-1044,12225666,06466.8%
2025-09-0940,070057,00170.3%
2025-09-0860,8490100,07860.8%
2025-09-0521,256044,07648.2%
2025-09-0434,642075,10446.1%
2025-09-0318,550034,66653.5%
2025-09-0214,573029,08950.1%
2025-08-2926,726061,35043.6%
2025-08-2813,200025,93950.9%
2025-08-2711,079017,77362.3%
2025-08-2611,978025,77946.5%
2025-08-2512,753015,62881.6%
2025-08-2224,392036,99665.9%
2025-08-2121,835029,11875.0%
2025-08-2017,748020,40587.0%
2025-08-1916,376020,05681.7%
2025-08-1824,845033,74673.6%
2025-08-1538,699050,73076.3%
2025-08-1428,447041,08769.2%
2025-08-1330,727041,49474.1%
2025-08-1222,059029,87473.8%
2025-08-1133,535044,43975.5%
2025-08-0844,773051,57386.8%
2025-08-0747,023070,94766.3%
2025-08-0666,1382,618116,95256.6%
2025-08-0548,1512,57779,09660.9%
2025-08-0418,085030,00360.3%
2025-08-0132,642144,83472.8%
2025-07-3123,535028,29483.2%
2025-07-3021,088028,52773.9%
2025-07-2913,834020,24168.3%
2025-07-2818,435023,81277.4%
2025-07-2514,516020,18771.9%
2025-07-2432,558042,02777.5%
2025-07-2333,147744,62474.3%
2025-07-2237,85430646,90380.7%
2025-07-2131,176046,12767.6%
2025-07-1833,504056,45959.3%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy